8 December

Gregory Daco, an economist, shared an article on the greatest vaccine effort in history, with the UK leading the pack to clear the first shot from Pfizer and BioNTech. The US is also making similar efforts and has succeeded in developing the Moderna vaccine candidate, mRNA-1273, which revealed 94.5% efficacy in its early stage data.

Experts believe that by the end of the year millions will be inoculated, and billions across the globe. The article explains how nine potential vaccines are being tracked around the globe, on the basis of national procurement deals to patients being administered doses. According to the data collected, 7.85 million doses of Covid-19 vaccines have already been allotted.

Economists believe that this maybe enough to meet the vaccine requirements of at least half the world, if administered evenly. However, it is a fact that the economically richer countries have placed higher bets on these vaccines with extensive supply agreements, while the need for ultra-cold storage requirements make it even more difficult for tropical countries and emerging markets to bag the vaccine deals, the article detailed.

Meanwhile, countries like Russia and China are carving their own path and are most likely to depend on domestically produced vaccines such as the Sputnik V and Sinopharm-made vaccine. The two countries authorised these vaccines in July and expect their entire populations to be vaccinated.

Read more

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.